407 related articles for article (PubMed ID: 37183304)
1. Retracted: Chen, Y, Zhang, W, Kadier, A, Zhang, H, Yao, X. MicroRNA-769-5p suppresses cell growth and migration via targeting NUSAP1 in bladder cancer. J Clin Lab Anal. 2020; 34:e23193.
J Clin Lab Anal; 2023 Apr; 37(8):e24893. PubMed ID: 37183304
[TBL] [Abstract][Full Text] [Related]
2. RETRACTED: Physcion 8-O-β-glucopyranoside induced ferroptosis via regulating miR-103a-3p/GLS2 axis in gastric cancer.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Life Sci; 2019 Nov; 237():116893. PubMed ID: 31606381
[TBL] [Abstract][Full Text] [Related]
3. RETRACTED: Alpinumisoflavone causes DNA damage in Colorectal Cancer Cells via blocking DNA repair mediated by RAD51.
Li D; Li X; Li G; Meng Y; Jin Y; Shang S; Li Y
Life Sci; 2019 Jan; 216():259-270. PubMed ID: 30448264
[TBL] [Abstract][Full Text] [Related]
4. Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.
FEBS Open Bio; 2023 Aug; 13(8):1540. PubMed ID: 37410095
[TBL] [Abstract][Full Text] [Related]
5. Retraction.
J Cell Biochem; 2021 Nov; 122(11):1761. PubMed ID: 34111302
[TBL] [Abstract][Full Text] [Related]
6. Retraction.
J Cell Biochem; 2021 Nov; 122 Suppl 1():S18. PubMed ID: 34107073
[TBL] [Abstract][Full Text] [Related]
7. RETRACTED: Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis.
Wang Q; Yan Y; Zhang J; Guo P; Xing Y; Wang Y; Qin F; Zeng Q
Biomed Pharmacother; 2018 Aug; 104():28-35. PubMed ID: 29758413
[TBL] [Abstract][Full Text] [Related]
8. Retraction.
J Cell Physiol; 2021 Dec; 236(12):8264. PubMed ID: 34086972
[TBL] [Abstract][Full Text] [Related]
9. Retraction.
J Cell Biochem; 2021 Nov; 122(11):1764. PubMed ID: 34383349
[TBL] [Abstract][Full Text] [Related]
10. Retraction.
J Cell Biochem; 2021 Nov; 122 Suppl 1():S19. PubMed ID: 34107071
[TBL] [Abstract][Full Text] [Related]
11. Retraction.
J Cell Physiol; 2022 May; 237(5):2594. PubMed ID: 35297049
[TBL] [Abstract][Full Text] [Related]
12. Retracted: Resveratrol inhibits oesophageal adenocarcinoma cell proliferation via AMP-activated protein kinase signaling.
Asian Pac J Cancer Prev; 2017 Nov; 18(10):2895-2895. PubMed ID: 29171745
[TBL] [Abstract][Full Text] [Related]
13. Retraction.
J Cell Physiol; 2022 Mar; 237(3):2003. PubMed ID: 34287855
[TBL] [Abstract][Full Text] [Related]
14. Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
Asia Pac J Clin Oncol; 2023 Dec; 19(6):762. PubMed ID: 37888963
[TBL] [Abstract][Full Text] [Related]
15. Retraction.
J Cell Physiol; 2022 Feb; 237(2):1618. PubMed ID: 34087006
[TBL] [Abstract][Full Text] [Related]
16. Retraction.
J Cell Biochem; 2021 Nov; 122 Suppl 1():S24. PubMed ID: 34107069
[TBL] [Abstract][Full Text] [Related]
17. Retraction.
J Cell Biochem; 2021 Apr; 122(3-4):485. PubMed ID: 33590515
[TBL] [Abstract][Full Text] [Related]
18. Retraction: YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway.
Int J Cancer; 2024 Mar; 154(5):E5. PubMed ID: 38059668
[TBL] [Abstract][Full Text] [Related]
19. Retraction.
J Cell Physiol; 2021 Dec; 236(12):8256. PubMed ID: 34105163
[TBL] [Abstract][Full Text] [Related]
20. Retraction.
J Cell Biochem; 2021 Nov; 122 Suppl 1():S99. PubMed ID: 34288050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
